NCT00601302View on ClinicalTrials.gov

Bioequivalency Study of Amlodipine Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

May 31, 2004

Conditions
HypertensionChronic Stable AnginaVasospastic Angina
Interventions
DRUG

Amlodipine

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00601302 - Bioequivalency Study of Amlodipine Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter